6 September 2017 in Science Translational Medicine
A handheld and biocompatible mass spectrometry system provides nondestructive molecular diagnosis of cancer tissue samples.
6 July 2021 in Proceedings of the National Academy of Sciences
Significance: Surgical removal of pancreatic cancer remains the only option for a cure. To verify the extent of tumor removal, surgeons rely on pathologic evaluation of frozen sections of surgical margins. However, this process can be challenging, time consuming, and subjective. Here, we used the MasSpec Pen to rapidly distinguish pancreatic cancer from healthy pancreatic and bile duct tissues by generating classification models based on the molecular signatures acquired from tissue. We evaluated this technology in an operating room during pancreatic surgeries and used these classification models to predict on data obtained in vivo and ex vivo with high performance. Our results suggest that the MasSpec Pen platform has the potential to improve and expedite margin evaluation during pancreatic cancer surgery.
26 March 2014 in Analytical Chemistry
7 October 2019 in Proceedings of the National Academy of Sciences
Thyroid neoplasia is common and requires appropriate clinical workup with imaging and fine-needle aspiration (FNA) biopsy to evaluate for cancer. Yet, up to 20% of thyroid nodule FNA biopsies will be indeterminate in diagnosis based on cytological evaluation. Genomic approaches to characterize the malignant potential of nodules showed initial promise but have provided only modest improvement in diagnosis. Here, we describe a method using metabolic analysis by desorption electrospray ionization mass spectrometry (DESI-MS) imaging for direct analysis and diagnosis of follicular cell-derived neoplasia tissues and FNA biopsies. DESI-MS was used to analyze 178 tissue samples to determine the molecular signatures of normal, benign follicular adenoma (FTA), and malignant follicular carcinoma (FTC) and papillary carcinoma (PTC) thyroid tissues. Statistical classifiers, including benign thyroid versus PTC and benign thyroid versus FTC, were built and validated with 114,125 mass spectra, with accuracy assessed in correlation with clinical pathology. Clinical FNA smears were prospectively collected and analyzed using DESI-MS imaging, and the performance of the statistical classifiers was tested with 69 prospectively collected clinical FNA smears. High performance was achieved for both models when predicting on the FNA test set, which included 24 nodules with indeterminate preoperative cytology, with accuracies of 93% and 89%. Our results strongly suggest that DESI-MS imaging is a valuable technology for identification of malignant potential of thyroid nodules.
26 January 2022 in Talanta
1 February 2009 in Sensor Letters